Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 31Neoplasms 20Motor Activity 12Lung Neoplasms 7Fatigue 7Colorectal Neoplasms 6Anxiety Disorders 6Stomach Neoplasms 4Polycystic Ovary Syndrome 4Pain, Postoperative 4Pain 4Depression 4Carcinoma, Hepatocellular 4Thyroid Neoplasms 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Malnutrition 3Vomiting 2Urinary Incontinence 2Stomatitis 2Rectal Neoplasms 2Peritoneal Neoplasms 2Parasomnias 2Ovarian Neoplasms 2Nausea 2Lymphedema 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hot Flashes 2Hematologic Neoplasms 2

Interventions

Photochemotherapy 6Aminolevulinic Acid 5Fluorouracil 4methyl 5-aminolevulinate 3Phototherapy 2Blue Light 23-ingenyl angelate 2tazarotene 1dexpanthenol 1calcipotriene 1Therapeutics 1Sunlight 1Retinoids 1Photosensitizing Agents 1Methylation 1Mass Screening 1Lasers, Dye 1Laser Therapy 1Imiquimod 1Gels 1Cryotherapy 1Control Groups 1Biopsy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Keratosis, Actinic × Control Groups × Clear all
NCT07335003 2026-01-12

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Cosmetique Active International

Phase NA Recruiting
80 enrolled
Dermatologic

Disease, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡